Next Article in Journal
Inhibition of Aβ Aggregation by Cholesterol-End-Modified PEG Vesicles and Micelles
Previous Article in Journal
Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics
Previous Article in Special Issue
Preparation and In Vitro/In Vivo Characterization of Mixed-Micelles-Loaded Dissolving Microneedles for Sustained Release of Indomethacin
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(12), 1631; https://doi.org/10.3390/pharmaceutics16121631
Action Date Notes Link
article xml file uploaded 23 December 2024 15:43 CET Original file -
article xml uploaded. 23 December 2024 15:43 CET Update -
article pdf uploaded. 23 December 2024 15:43 CET Version of Record https://www.mdpi.com/1999-4923/16/12/1631/pdf-vor
article supplementary file uploaded. 23 December 2024 15:43 CET - https://www.mdpi.com/1999-4923/16/12/1631#supplementary
article html file updated 23 December 2024 15:45 CET Original file -
article xml file uploaded 24 December 2024 14:56 CET Update -
article xml uploaded. 24 December 2024 14:56 CET Update -
article pdf uploaded. 24 December 2024 14:56 CET Updated version of record https://www.mdpi.com/1999-4923/16/12/1631/pdf-vor
article html file updated 24 December 2024 14:59 CET Update -
article xml file uploaded 26 December 2024 08:00 CET Update -
article xml uploaded. 26 December 2024 08:00 CET Update https://www.mdpi.com/1999-4923/16/12/1631/xml
article pdf uploaded. 26 December 2024 08:00 CET Updated version of record https://www.mdpi.com/1999-4923/16/12/1631/pdf
article html file updated 26 December 2024 08:01 CET Update https://www.mdpi.com/1999-4923/16/12/1631/html
Back to TopTop